eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Would you have Corneal clouding when you have Multiple sclerosis?

Summary: Corneal clouding is reported only by a few people with Multiple sclerosis.

We study people who have Corneal clouding and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone: join a support group for people who have Multiple sclerosis and Corneal clouding >>>

 

Multiple sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Tysabri, Copaxone, Avonex, Rebif, Betaseron, Baclofen. (latest reports from 224,273 Multiple Sclerosis patients)

Corneal clouding

Corneal clouding (cloudiness of cornea) has been reported by people with insomnia, obsessive-compulsive disorder, heart disease congenital, stress and anxiety, dermatitis atopic. (latest reports)

On Apr, 1, 2015: 1 people who has multiple sclerosis and Corneal Clouding is studied.

Trend of Corneal clouding in multiple sclerosis reports

Gender of people who have multiple sclerosis and experienced Corneal clouding * :

FemaleMale
Corneal clouding100.00%0.00%

Age of people who have multiple sclerosis and experienced Corneal clouding * :

0-12-910-1920-2930-3940-4950-5960+
Corneal clouding0.00%0.00%0.00%0.00%0.00%0.00%100.00%0.00%

Severity of the symptom * :

leastmoderateseveremost severe
Corneal clouding0.00%0.00%100.00%0.00%

Top co-existing conditions for these people * :

  1. Muscle spasticity (1 people, 100.00%)
  2. Neuropathic pain (1 people, 100.00%)

Most common drugs used by these people * :

  1. Betaseron (1 people, 100.00%)
  2. Baclofen (1 people, 100.00%)
  3. Gabapentin (1 people, 100.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of multiple sclerosis and corneal clouding on

Do you have Multiple Sclerosis and Corneal Clouding?

 

 

 

You are not alone! Join a support group on :
- support group for people who have Corneal Clouding and Multiple sclerosis
- support group for people who have Multiple sclerosis
- support group for people who have Corneal Clouding

Could your drug cause:

Other conditions that could cause:

Recent related drug studies (Check your drugs):

Recent Multiple Sclerosis related drug comparison:

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.